🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pharmacokinetics of 50 mg BIBR 1048 administered as two newly developed...
Status
Completed
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT02170805
Two substudies to assess (1) the tolerability of BIBR 953 ZW intravenous in...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT02170584
Treatments Being Tested
The objective of this study was to assess safety, pharmacokinetics and the ...
Status
Completed
Location
Multiple Locations
Start Date
1998-11
Trial ID
NCT02170116
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagul...
Status
Completed
Location
Multiple Locations
Start Date
1999-05
Trial ID
NCT02170831
Comparative pharmacokinetics of BIBR 1048 MS solution and tablet with or wi...
Status
Completed
Location
Multiple Locations
Start Date
1999-07
Trial ID
NCT02170922
Treatments Being Tested
Study to assess the amount of BIBR 953 ZW in urine and concentrations in pl...
Status
Completed
Location
Multiple Locations
Start Date
2002-02
Trial ID
NCT02170623
Treatments Being Tested
Study to assess the amount of BIBR 953 ZW in urine after administration of ...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT02170636
To assess the amount of BIBR 953 ZW in urine of 50 mg of BIBR 1048 bid over...
Status
Completed
Location
Multiple Locations
Start Date
2001-10
Trial ID
NCT02170896